Evidence map›Paper›PMID 29019091›Full record

ArticleInflammation2018

Preventive and Therapeutic Effects of Thymol in a Lipopolysaccharide-Induced Acute Lung Injury Mice Model.

Limei Wan, Dongmei Meng, Hong Wang, Shanhe Wan, Shunjun Jiang, Shanshan Huang, Li Wei, Pengjiu Yu

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Anti-Inflammatory Activities ofPlants (Basel, Switzerland) · 2023
    Article
  12. Journal of herbal medicine · 2023
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Limei WanDepartment of Respiratory Medicine, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, 510080, China.
Dongmei MengDepartment of Pharmacy, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China.
Hong WangDepartment of Respiratory Medicine, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, 510080, China.
Shanhe WanGuangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Science, Southern Medical University, Guangzhou, 510515, China.
Shunjun JiangDepartment of Pharmacy, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China.
Shanshan HuangDepartment of Pharmacy, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China.
Li WeiDepartment of Pharmacy, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China. runkingone@126.com.
Pengjiu YuDepartment of Pharmacy, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China. ypj725@163.com.ORCID http://orcid.org/0000-0002-9968-3280
First Affiliated Hospital of Guangzhou Medical University · CNFirst Affiliated Hospital of Guangdong Pharmaceutical University · CNSouthern Medical University · CN

Funding

Education Bureau of Guangzhou No.1201581610National Natural Science Foundation of China (CN) No.81402992
6 · The paper itself

Abstract

Acute lung injury (ALI) is a life-threatening syndrome which causes a high mortality rate worldwide. In traditional medicine, lots of aromatic plants-such as some Thymus species-are used for treatment of various lung diseases including pertussis, bronchitis, and asthma. Thymol, one of the primary active constituent derived from Thymus vulgaris (thyme), has been reported to exhibit potent anti-microbial, anti-oxidant, and anti-inflammatory activities in vivo and in vitro. The present study aims to investigate the protective effects of thymol in lipopolysaccharide (LPS)-induced lung injury mice model. In LPS-challenged mice, treatment with thymol (100 mg/kg) before or after LPS challenge significantly improved pathological changes in lung tissues. Thymol also inhibited the LPS-induced inflammatory cells influx, TNF-α and IL-6 releases, and protein concentration in bronchoalveolar lavage fluid (BALF). Additionally, thymol markedly inhibited LPS-induced elevation of MDA and MPO levels, as well as reduction of SOD activity. Further study demonstrated that thymol effectively inhibited the NF-κB activation in the lung. Taken together, these results suggested that thymol might be useful in the therapy of acute lung injury.

Indexed as

LipopolysaccharidesAcute Lung InjuryAnimalsAnti-Inflammatory AgentsBronchoalveolar Lavage FluidDisease Models, AnimalDose-Response Relationship, DrugInflammation MediatorsInterleukin-6LungMaleMalondialdehydeMice, Inbred BALB CNF-kappa BOxidative StressPeroxidaseAnti-Inflammatory AgentsInflammation MediatorsInterleukin-6interleukin-6, mouselipopolysaccharide, E coli O55-B5LipopolysaccharidesMalondialdehydeNF-kappa BPeroxidaseSuperoxide DismutaseThymolTumor Necrosis Factor-alphaacute lung injurylipopolysaccharidethymol

Identifiers

PMID29019091
OpenAlexW2762734082

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.